CELEX: 62020TN0637
Language: en
Date: 2020-10-21 00:00:00
Title: Case T-637/20: Action brought on 21 October 2020 — Dermavita Company v EUIPO — Allergan Holdings France (JUVÉDERM VOLITE)

21.12.2020   
            
            
               EN
            
            
               Official Journal of the European Union
            
            
               C 443/26
            
         
      Action brought on 21 October 2020 — Dermavita Company v EUIPO — Allergan Holdings France (JUVÉDERM VOLITE)
      (Case T-637/20)
      (2020/C 443/31)
      Language of the case: English
      
         Parties
      
      
         Applicant: Dermavita Company SARL (Beirut, Lebanon) (represented by: D. Todorov, lawyer)
      
         Defendant: European Union Intellectual Property Office (EUIPO)
      
         Other party to the proceedings before the Board of Appeal: Allergan Holdings France SAS (Courbevoie, France)
      
         Details of the proceedings before EUIPO
      
      
         Proprietor of the trade mark at issue: Other party to the proceedings before the Board of Appeal
      
         Trade mark at issue: European Union word mark JUVÉDERM VOLITE –European Union trade mark No 13 413 406
      
         Procedure before EUIPO: Cancellation proceedings
      
         Contested decision: Decision of the Fourth Board of Appeal of EUIPO of 21 August 2020 in Case R 1015/2020-4
      
         Form of order sought
      
      The applicant claims that the Court should:
      
                  —
               
               
                  annul the contested decision;
               
            
                  —
               
               
                  ask EUIPO to deem the appeal filed;
               
            
                  —
               
               
                  order EUIPO and the other party to bear their own costs and pay those of the Applicant before the General Court.
               
            
         Plea in law
      
      
                  —
               
               
                  Infringement of Articles 101(4), 104, 106 and 107 of Regulation (EU) 2017/1001 of the European Parliament and of the Council.